Bill Commons

AL HB 127

died on adjournment

Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.

Alabama · 2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did AL HB 127 pass?

No. AL HB 127 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-13): Read for the first time and referred to the House Committee on Health

What is AL HB 127 about?

Occupational Licensing Boards

Who sponsors AL HB 127?

Brown (C) is the primary sponsor of AL HB 127.

Description

Occupational Licensing Boards

Introduced
—
Latest action
2026-01-13 — Read for the first time and referred to the House Committee on Health
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Brown (C)primary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-01-13

    Read for the first time and referred to the House Committee on Health

    reading-1,referral-committee

  2. 2026-01-13

    Pending Committee Action in House of Origin (Health)

  3. 2026-01-07

    Filed

    filing

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T03:48:16.489444Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=AL&identifier=HB 127. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.